RightFit Trial Directory

Colorectal Cancer clinical trials in Tampa, FL

24 recruiting colorectal cancer studies with a site in Tampa, FL.

All trials in Tampa, FL · All Colorectal Cancer trials

RecruitingPhase 3NCT07525206

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Sponsor: AbbVie

Tampa, FL · +17 more sites

RecruitingPhase 2NCT07023289

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Sponsor: AbbVie

Jacksonville, FL · Tampa, FL · +20 more sites

RecruitingPhase 1NCT07114601

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Sponsor: Eli Lilly and Company

Miami, FL · Tampa, FL · +14 more sites

RecruitingPhase 1NCT04429542

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Sponsor: Bicara Therapeutics

Tampa, FL · +14 more sites

RecruitingPhase 2NCT07446322

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Sponsor: Oncolytics Biotech

Tampa, FL · +16 more sites

RecruitingPhase 1NCT07544589

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Sponsor: Dispatch Biotherapeutics

Tampa, FL · +6 more sites

RecruitingNot applicableNCT05612347

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Sponsor: Dartmouth-Hitchcock Medical Center

Tampa, FL · +19 more sites

RecruitingPhase 1NCT07085091

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Sponsor: ALX Oncology Inc.

Tampa, FL · +11 more sites

RecruitingPhase 1NCT05877599

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Sponsor: AstraZeneca

Jacksonville, FL · Miami, FL · Tampa, FL · +17 more sites

RecruitingPhase 1 / Phase 2NCT06445062

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Sponsor: Revolution Medicines, Inc.

Jacksonville, FL · Tampa, FL · +30 more sites

RecruitingPhase 1 / Phase 2NCT07629960

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Sponsor: Blueprint Medicines Corporation

Sarasota, FL · Tampa, FL · +8 more sites

RecruitingPhase 1NCT07020117

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Sponsor: Aktis Oncology, Inc.

Miami, FL · Orlando, FL · Tampa, FL · +11 more sites

RecruitingPhase 1NCT07487168

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Tampa, FL

RecruitingPhase not listedNCT06880055

Shield Post-Approval Study Protocol

Sponsor: Guardant Health, Inc.

Boca Raton, FL · Delray Beach, FL · Doral, FL · +66 more sites

RecruitingPhase 1NCT06974110

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Sponsor: MOMA Therapeutics

Tampa, FL · +8 more sites

RecruitingPhase 1 / Phase 2NCT06051695

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Sponsor: A2 Biotherapeutics Inc.

Jacksonville, FL · Tampa, FL · +10 more sites

RecruitingPhase 1NCT06917079

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Tampa, FL · +15 more sites

RecruitingPhase 1 / Phase 2NCT04421820

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Sponsor: Bold Therapeutics, Inc.

Tampa, FL · +1 more sites

RecruitingPhase 1 / Phase 2NCT05379985

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Sponsor: Revolution Medicines, Inc.

Tampa, FL · +20 more sites

RecruitingPhase 1 / Phase 2NCT06682793

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Sponsor: A2 Biotherapeutics Inc.

Jacksonville, FL · Tampa, FL · +8 more sites

RecruitingPhase 2NCT03175224

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Sponsor: Apollomics Inc.

Tampa, FL · +5 more sites

RecruitingPhase not listedNCT02328677

ColoCare Study - Colorectal Cancer Cohort

Sponsor: University of Utah

Tampa, FL · +5 more sites

RecruitingPhase 1NCT04991948

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Sponsor: Celyad Oncology SA

Jacksonville, FL · Tampa, FL

RecruitingPhase 1NCT03692429

alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

Sponsor: Celyad Oncology SA

Tampa, FL

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.